Avacta Group chief executive Dr Alastair Smith will be presenting at the annual Biotech Showcase which is being held in San Francisco on 8-10 Jan.

Smith will outline the key benefits of the group's Affimer technology as a therapeutic protein platform and update the meeting on progress within the therapeutic programmes.

The presentation will be available on Avacta's website (www.avacta.com).